Anthracyclines/pembrolizumabMyocarditis: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2035卷 / 1期

关键词：

D O I：

10.1007/s40278-024-70794-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：44 / 44

相关论文

共 50 条

[21] PembrolizumabMyocarditis: case report
Reactions Weekly, 2019, 1776 (1) : 365 - 365
[22] PembrolizumabMyocarditis: case report
Reactions Weekly, 2025, 2049 (1) : 308 - 308
[23] PembrolizumabMyocarditis: case report
Reactions Weekly, 2023, 1964 (1) : 353 - 353
[24] Anthracyclines/antineoplastics/immunosuppressantsRenal cancer: 5 case reports
Reactions Weekly, 2006, 1107 (1) : 6 - 6
[25] PembrolizumabMyocarditis : case report
Reactions Weekly, 2023, 1949 (1) : 355 - 355
[26] Anthracyclines/trastuzumabCongestive heart failure: 16 case reports
Reactions Weekly, 2014, 1527 (1) : 33 - 33
[27] Anthracyclines/cyclophosphamide/etoposideSecondary malignancies: 14 case reports
Reactions Weekly, 2019, 1741 (1) : 28 - 28
[28] PembrolizumabMyocarditis: case report
Reactions Weekly, 2022, 1912 (1) : 374 - 374
[29] PembrolizumabMyocarditis: case report
Reactions Weekly, 2020, 1822 (1) : 240 - 240
[30] PembrolizumabMyocarditis: case report
Reactions Weekly, 2024, 2021 (1) : 439 - 439

← 1 2 3 4 5 →